IHC staining of GBM patient tissue for HOXC6 resulted in most GBM patients showing HOXC6 expression, whereas no expression was seen in normal control tissues, thus confirming the results seen in the bioinformatic analysis. This evidence concerns the gene HOXC6 and glioblastoma.